Skip to content

DMT: all studies

Page 96 of 160: studies 951 to 960 of 1,593, newest first. Back to the DMT overview

Research

The Effects of Psychedelic Microdosing on Mental Health: A Systematic Review

Research Posters May 2, 2024 David F Lo, Hasan Zia, Adarsh Thakur et al. 1 citation

This poster explores the effects of psychedelic microdosing on mental health conditions. Roughly 5.5 million individuals in the U.S. utilize psychedelics to treat their mental health issues. The primary substances used for microdosing currently include LSD and psilocybin, but mescaline, DMT, and amphetamines are used less commonly. This systematic review included 16 unique articles. The types...

From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream Medicine

European Journal of Arts Humanities and Social Sciences May 1, 2024 Nicholas A. Kerna, Kevin D. Pruitt, N.d. Victor Carsrud et al.

Entheogens, a class of psychoactive substances with profound cultural and religious significance, have been utilized for centuries across diverse traditions for healing, spiritual exploration, and communication with the divine. Their historical usage spans continents, from the pre-Columbian Americas to traditional African practices and Ayurvedic medicine in India. While entheogens offer...

DOI: 10.59324/ejahss.2024.1(3).10 (opens in new tab) The venerable Mainstream Classics Law

Suspension of Short‐lasting, Unilateral, Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) symptoms with ayahuasca and serotonergic psychedelics

Headache: The Journal of Head and Face Pain May 1, 2024 Jonathan A. Leighton, Cyril Petignat, Brian E. Mcgeeney 2 citations

Plain Language Summary A suicidal patient with Short‐lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) whose excruciating condition did not respond to various treatments discovered that ayahuasca, a psychoactive concoction used by indigenous populations of South America, caused his attacks to cease entirely. Inhaled N , N ‐dimethyltryptamine (DMT),...

Expectancy Effects in Psychedelic Trials.

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging May 1, 2024 Balázs Szigeti, Boris D. Heifets 62 citations

Clinical trials of psychedelic compounds like psilocybin, lysergic acid diethylamide (LSD), and N,N-dimethyltrptamine (DMT) have forced a reconsideration of how nondrug factors, such as participant expectations, are measured and controlled in mental health research. As doses of these profoundly psychoactive substances increase, so does the difficulty in concealing the treatment condition in the...

DOI: 10.1016/j.bpsc.2024.02.004 (opens in new tab) Full text (opens in new tab) Microdosing Hallucinogen therapy Clinical-trials trial design Psychedelic-therapy psychedelic medicine +6

Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis.

Psychiatry Research May 1, 2024 Yuan Yao, Dan Guo, Tang-Sheng Lu et al. 126 citations

We aim to systematically review and meta-analyze the effectiveness and safety of psychedelics [psilocybin, ayahuasca (active component DMT), LSD and MDMA] in treating symptoms of various mental disorders. Web of Science, Embase, EBSCO, and PubMed were searched up to February 2024 and 126 articles were finally included. Results showed that psilocybin has the largest number of articles on...

DOI: 10.1016/j.psychres.2024.115886 (opens in new tab) Full text (opens in new tab) Mental disorders Meta-analysis Safety Psychedelics hallucinogens +5

The identification of psychedelic compounds within Australian Acacia species

Australian Journal of Forensic Sciences April 28, 2024 L. O'Grady, X. Conlan, L. Webb

ABSTRACT N,N-dimethyltryptamine (DMT) is a psychedelic substance produced within various Acacia species; however, the range of species that contain it and the quantity of the compound found within each species is relatively unknown. This work focused on the identification of DMT in 104 plant samples, representing 79 Acacia species, utilizing a reverse phase liquid chromatographic separation...

Discovery and Structure–Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT2A Receptor Agonists

Journal of Medicinal Chemistry April 22, 2024 Karla Frydenvang, Emil Märcher-Rørsted, Anders A. Jensen et al. 7 citations

Classical psychedelics such as psilocybin, lysergic acid diethylamide (LSD), and N,N-dimethyltryptamine (DMT) are showing promising results in clinical trials for a range of psychiatric indications, including depression, anxiety, and substance abuse disorder. These compounds are characterized by broad pharmacological activity profiles, and while the acute mind-altering effects can be ascribed...

DOI: 10.1021/acs.jmedchem.4c00082 (opens in new tab) Pharmacology 5-HT Receptor Structure–activity relationship Serotonin agonist +1

Plant Medicine, Psychedelics and the Inner-Sciences of Mental Wellness: Implications for Healthy Longevity and Rejuvenation

International Journal of Translational Science April 20, 2024 Jeffrey L. Mcnairy

Rythmia Life Advancement Center is the first and currently only medically licensed Ayahuasca center in the world. Rythmia is helping to bridge the gap between the Western medical model of health care with the indigenous healing modalities of Latin America. The “Rythmia Way” program uses a variety of modalities, in addition to Ayahuasca, to help individuals find meaning in their lives and...

The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodents

bioRxiv Preprint Server April 19, 2024 Anders A. Jensen, Cláudia R. Cecchi, Meghan Hibicke et al. preprint

Psychedelic-assisted psychotherapy has over the last decade emerged as a promising treatment strategy for mental health disease, and the therapeutic potential in classical psychedelics such as psilocybin, LSD and 5-MeO-DMT is presently being pursued in a plethora of clinical trials. However, the resurgent interest in the drugs as therapeutics has also prompted a search for novel agents with...

Trips Through the Skin: Reviewing Cutaneous Drug Reactions to Psychedelics and Hallucinogens

Dermatitis April 18, 2024 Syed Minhaj Rahman, Yousef Salem, Aamir Hussain 4 citations

Although psychedelic and hallucinogenic substances have gained popularity for therapeutic use, their dermatologic adverse effects are poorly characterized. This review characterizes the cutaneous reactions associated with psychedelic and hallucinogenic drugs. A review of PubMed and Scopus was conducted from the inception of databases to August 31, 2023. Search terms included drug names and...

DOI: 10.1089/derm.2023.0292 (opens in new tab) Psilocybin Hallucinogen Trips architecture Dermatology